Yvonne Hui Sells 582 Shares of Phreesia, Inc. (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) insider Yvonne Hui sold 582 shares of the stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $28.00, for a total value of $16,296.00. Following the completion of the transaction, the insider now owns 31,010 shares of the company's stock, valued at $868,280. The trade was a 1.84% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Yvonne Hui also recently made the following trade(s):

• On Monday, April 21st, Yvonne Hui sold 993 shares of Phreesia stock. The shares were sold at an average price of $23.04, for a total value of $22,878.72.
• On Tuesday, April 15th, Yvonne Hui sold 314 shares of Phreesia stock. The shares were sold at an average price of $24.04, for a total value of $7,548.56.
• On Tuesday, April 8th, Yvonne Hui sold 1,878 shares of Phreesia stock. The stock was sold at an average price of $23.85, for a total value of $44,790.30.

Phreesia Stock Down 2.4%

Shares of PHR traded down $0.64 during mid-day trading on Friday, hitting $25.99. The company's stock had a trading volume of 448,368 shares, compared to its average volume of 443,599. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $30.53. The company's 50-day moving average is $25.01 and its 200-day moving average is $25.77. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The firm has a market capitalization of $1.55 billion, a price-to-earnings ratio of -17.68 and a beta of 0.68.

Phreesia (NYSE:PHR - Get Free Report) last released its quarterly earnings data on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. The firm had revenue of $115.94 million for the quarter, compared to analyst estimates of $115.00 million. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business's quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.05) earnings per share. On average, equities research analysts forecast that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on PHR. Citigroup reissued a "buy" rating on shares of Phreesia in a report on Wednesday, May 28th. Needham & Company LLC restated a "buy" rating and set a $29.00 price target on shares of Phreesia in a research report on Thursday, March 13th. Wall Street Zen upgraded shares of Phreesia from a "hold" rating to a "buy" rating in a report on Sunday, June 1st. Truist Financial increased their price target on shares of Phreesia from $34.00 to $35.00 and gave the stock a "buy" rating in a research note on Thursday, May 29th. Finally, Canaccord Genuity Group decreased their target price on shares of Phreesia from $35.00 to $34.00 and set a "buy" rating for the company in a research note on Thursday, May 29th. Twelve equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has an average rating of "Buy" and an average target price of $31.64.

Institutional Investors Weigh In On Phreesia

A number of institutional investors and hedge funds have recently made changes to their positions in PHR. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Phreesia by 108.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,644,988 shares of the company's stock valued at $67,606,000 after acquiring an additional 1,377,904 shares during the period. American Century Companies Inc. grew its holdings in shares of Phreesia by 3,741.9% in the first quarter. American Century Companies Inc. now owns 983,440 shares of the company's stock valued at $25,137,000 after purchasing an additional 957,842 shares in the last quarter. Deerfield Management Company L.P. Series C grew its holdings in shares of Phreesia by 133.6% in the fourth quarter. Deerfield Management Company L.P. Series C now owns 1,271,832 shares of the company's stock valued at $31,999,000 after purchasing an additional 727,384 shares in the last quarter. Greenhouse Funds LLLP grew its holdings in shares of Phreesia by 27.9% in the fourth quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company's stock valued at $72,307,000 after purchasing an additional 626,579 shares in the last quarter. Finally, Nuveen LLC acquired a new position in shares of Phreesia in the first quarter valued at approximately $14,206,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.